Results 251 to 260 of about 1,005,947 (300)
Viruses, 2022 The poultry industry is the largest source of meat and eggs for human consumption worldwide. However, viral outbreaks in farmed stock are a common occurrence and a major source of concern for the industry.
Mookkan Prabakaran
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Annual Review of Medicine, 1985
Purified from the plasma of hepatitis B carriers, hepatitis B surface antigen particles have been used in a vaccine to prevent hepatitis B. This plasma-derived vaccine is immunogenic, protective, and has an excellent safety record. Indications and strategies for preexposure and postexposure prophylaxis are reviewed.
I M, Jacobson, J L, Dienstag
openaire +2 more sources
Purified from the plasma of hepatitis B carriers, hepatitis B surface antigen particles have been used in a vaccine to prevent hepatitis B. This plasma-derived vaccine is immunogenic, protective, and has an excellent safety record. Indications and strategies for preexposure and postexposure prophylaxis are reviewed.
I M, Jacobson, J L, Dienstag
openaire +2 more sources
Annual Review of Microbiology, 1984
INTRODUCTION...... ..... 221 Vaccines in the Control of Virus Diseases .....
openaire +2 more sources
INTRODUCTION...... ..... 221 Vaccines in the Control of Virus Diseases .....
openaire +2 more sources
Vaccines to Prevent Viral Hepatitis
New England Journal of Medicine, 1997At least five different viruses cause hepatitis in humans. Two — hepatitis A virus (HAV) and hepatitis E virus (HEV) — are nonenveloped RNA viruses that are spread predominantly by fecal–oral transmission and cause acute self-limited disease.1,2 The others — hepatitis B virus (HBV), hepatitis delta virus (HDV), and hepatitis C virus (HCV) — are ...
Stanley M Lemon
exaly +3 more sources
Intradermal administration of viral vaccines
Reviews in Medical Virology, 1998Intradermal administration maybe useful in lowering the cost of vaccination against hepatitis B significantly, and may also be helpful for the rapid induction of antibodies, reversing non-responsiveness, improving postexposure prophylaxis and immunising immunocompromised people.
, Nagafuchi +4 more
openaire +2 more sources
Seminars in Oncology, 2005
Recent advances in understanding tumor-specific immunity have introduced new excitement in the clinical development of vaccines for the treatment of cancer. A better understanding of basic immunologic principles has led to a variety of techniques for enhancing tumor-specific immunity through vaccination.
Philip M, Arlen +2 more
openaire +2 more sources
Recent advances in understanding tumor-specific immunity have introduced new excitement in the clinical development of vaccines for the treatment of cancer. A better understanding of basic immunologic principles has led to a variety of techniques for enhancing tumor-specific immunity through vaccination.
Philip M, Arlen +2 more
openaire +2 more sources
Viral Vaccines for Cancer Immunotherapy
Hematology/Oncology Clinics of North America, 2006The understanding that tumor cells can be recognized and eliminated by the immune system has led to intense interest in the development of cancer vaccines. Viruses are naturally occurring agents that cause human disease but have the potential to prevent disease when attenuated forms or subunits are used as vaccines before exposure.
Andrew, Eisenberger +2 more
openaire +2 more sources
DNA vaccines for viral diseases
Microbes and Infection, 1999DNA vaccines, with which the antigen is synthesized in vivo after direct introduction of its encoding sequences, offer a unique method of immunization that may overcome many of the deficits of traditional antigen-based vaccines. By virtue of the sustained in vivo antigen synthesis and the comprised stimulatory CpG motifs, plasmid DNA vaccines appear to
H L, Davis, M J, McCluskie
openaire +2 more sources
Viral vectors as vaccine carriers
Current Opinion in Virology, 2016This chapter reviews the performance of viral vectors based on adenoviruses or adeno-associated virus as vaccine carriers for infectious diseases. Replication-defective adenovirus vectors based on multiple human or non-human serotypes have consistently induced potent transgene product-specific B and T cell responses and are increasingly being explored ...
openaire +2 more sources